PATENT CLAIM ANALYSIS

Application Number: 15992497
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["424", "203100"]

Abstract:
Described are immunogenic proteins against  Clostridium difficile . Also described are compositions comprising the immunogenic proteins. Further described are methods of preventing or treating a  Clostridium difficile  infection in a subject in need thereof.

Claim (Index 20):
A method of treating a  Clostridium difficile  bacterial infection in a subject in need thereof, the method comprising administering to the subject the pharmaceutical composition of  claim 19 .

Metadata:
- Claim Count in Document: 8.0
- Percentile: 93.0
- Lexical Diversity: 1.44
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15905598', '14374792', '15119323', '15191739', '14529147']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7094664649729903
- 35 USC 102 Novelty (BERT): 0.5863675836731336
- Combined Prediction Score: 0.6971565768430046
- Mean Citation Score: 428.11094800000006
- Max Citation Score: 572.0629
- Similarity Product: 375.9353800778866

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test